Sub-Tenon's block for cataract surgery is an increasingly common technique. While this technique has been successfully applied, the optimal local anaesthetic solution is not known. This study was performed to assess any differences in anaesthesia and oculomotor block between 1% ropivacaine and a 2% lignocaine with 0.5% bupivacaine mixture. The results indicate that there was no difference noted in the clinical effect between the solutions. "Who are you going to believe, me or your own eyes? " -Groucho Marx (1890-1977 
Regional anaesthesia is the technique of choice for cataract surgery. The injection of local anaesthetic within the sub-Tenon's space is a technique that has become increasingly popular with anaesthetists due to its advantages in efficacy and risk profile 1 .
The technique was initially described by Stevens in 1992 2 . More recently, the technique has been evaluated by Guise 3 in a prospective study of 6000 patients, demonstrating an excellent quality of anaesthesia, and a demonstrably improved risk profile when compared to conventional peri-and retrobulbar techniques of ocular anaesthesia.
The ideal solution should have a rapid onset, a high quality of anaesthesia and duration adequate for both the procedure and allowance for delay before commencement of surgery. There are also issues of cost, convenience and sterility of the solutions used. The solution traditionally used has been a mixture of lignocaine and bupivacaine 4 .
Ropivacaine is a newer aminoamide local anaesthetic, which appears to have a lower potential for cardiac and central nervous system toxicity 5, 6 . Its pharmacokinetic properties allow for a longer duration than a block with lignocaine alone, which has also been used in sub-Tenon's blocks 2 . There would also be advantages of convenience and improved sterility of using just a single agent and a theoretically better safety profile when compared with the use of a solution containing bupivacaine.
This study was, therefore, set up as a prospective, randomized double-blind controlled trial to address any differences between ropivacaine and the traditional solution with regards to ophthalmic anaesthesia, perioperative analgesia, akinesia of the globe and orbicularis muscle in the context of a sub-Tenon's block. Records were also made of any complications associated with the solutions, such as pain on injection and overall satisfaction.
METHODS
The study was approved by the local Ethics and Drug Trials committees and all patients gave written informed consent.
One hundred patients scheduled for routine cataract extraction and intraocular lens implantation at Concord Repatriation General Hospital were prospectively randomized to one of two groups. Exclusion criteria included patient refusal, known allergy to local anaesthetics and physical features that precluded the use of a sub-Tenon's block, such as a large pterygium or the presence of a retinal band.
Patient randomization was done by the hospital pharmacy using a computer generated random number sequence. Solutions were then prepared in identical 5 ml sterile syringes the day before surgery, appropriately stored and labelled with only the patient allocation number. Group A received 1% ropivacaine and hyaluronidase 15 U/ml while Group B received a 1:1 mixture of 2% lignocaine with 0.5% bupivacaine and 15 U/ml of hyaluronidase. A sub-Tenon's block was performed either by one of the investigators, or by a registrar under one of the investigators' direct supervision.
On arrival in the anaesthetic bay, the patient was positioned supine, venous access was obtained and pulse oximetry monitoring commenced. None of the patients were premedicated. All patients received three drops of 1% amethocaine topically to the eye undergoing surgery and the sub-Tenon's block was performed at least two minutes after the last amethocaine drop.
The sub-Tenon's block was performed aseptically with the skin around the eye prepared with povidoneiodine solution and an adherent sterile plastic drape placed around the appropriate eye. A lid speculum was inserted and the patient directed to look "upward and outward" to expose the inferonasal quadrant. The conjunctiva and anterior portion of Tenon's capsule would then be grasped with a small pair of forceps at least 5 mm from the limbus, midway between the inferior and medial recti, taking care to avoid conjunctival vessels. A small 1-2 mm cut of the conjunctiva and Tenon's capsule with a pair of sharppointed, curved spring scissors was then made such that bare sclera was visible.
A commercially available, purpose-designed, 19 gauge curved blunt-tipped sub-Tenon's cannula was then inserted and passed inferonasally through this cut, aiming to direct the cannula between the global insertions of the medial and inferior rectus muscles. The cannula itself was used to gently dissect its way around the globe-hence limiting the conjunctival incision. After advancing the cannula beyond the variable equatorial adherence of Tenon's capsule, the patient was directed to look "straight ahead"positioning the globe in a neutral position. The cannula was positioned with the curve of the cannula hugging the curve of the globe while being perpendicular to the anterior plane of the globe. A slow injection, taking 20 to 30 seconds, of the provided anaesthetic solution was then commenced. Correct positioning of the cannula in the posterior sub-Tenon's space was evidenced by the easy injection of local anaesthetic and proptosis of the eyeball without undue swelling of the inferior orbital fornix. In all cases, 4 ml of the randomized solution was used in the initial injection.
Following completion of the injection, the lid speculum was removed and a weight (Honan's mercury-filled balloon) was applied over the appropriately closed eyelid. The weight was applied for ten minutes, being lifted for the observations mentioned below.
Ocular and eyelid movement were assessed at one, five and ten minutes after the completion of the injection. Observations were charted according to the system originally described by Brahma 7 et al and since used and validated in other studies 8, 9 . Ocular movement was assessed for each direction of gazespecifically abduction, adduction, elevation and depression and scored where a total score of 12 represented normal ocular movement and 0 represented absence of ocular movement (Table 1) .
Forced eyelid closure was also scored as in Table  1 from 0 to 2. A total ocular score of 4 or less was considered adequate for surgery.
At the completion of surgery, patients were asked to verbally score any pain experienced during surgery (0 being no pain and 10 being the worst pain ever experienced). Routine intraoperative monitoring included ECG, non-invasive blood pressure and pulse oximetry. Any need for supplemental injections or further use of topical amethocaine was recorded. Any complications during or after the injection were noted. All patients received a mixture of air and oxygen (2 and 0.5 l/min respectively) via nasal prongs while their head was covered during surgery.
RESULTS

Demographic Data
The patients were randomly allocated with a demographic distribution reflected in Table 2 .
The mean eyeball axial length was 23.4 mm in the ropivacaine group and 23.6 mm in the lignocaine/ bupivacaine group. This measurement was done preoperatively by the surgeon when collecting data to assess lens implant requirements. The performance None of the 100 patients required a sub-Tenon's top up of local anaesthetic, although three from the ropivacaine group and four from Group B required supplemental topical amethocaine late in the procedure. If required, however, the addition of more local anaesthetic into the sub-Tenon's space would have been a simple process for the surgeon, instilling the solution into the tract already created from the initial injection.
Overall, there was only one patient from Group B who described anaesthesia as being inadequate.
The majority of patients who described any discomfort with surgery unfortunately (and curiously) described the symptoms either late towards the end of surgery or after its completion. There were five from the ropivacaine group and six from Group B. The anaesthesia however, was apparently adequate at the time of surgery with the pain scores less than three out of ten except for the one candidate from Group B who described it as five out of 10.
Using akinesia as a guide to adequate onset of block, satisfactory akinesia was defined as an ocular movement score of 4 or less. This was not achieved at 10 minutes in eight of the ropivacaine group and six of group B. Of these, only one candidate from group B was deemed to have unsatisfactory akinesia. Of note, the anaesthesia and akinesia in both groups were adequate for surgery, even allowing for delays in surgery of up to an hour following the initiation of the block. The cumulative results from both groups over time are illustrated in Figure 1 with ocular movement score compared between the groups in Table 3 .
There was no significant difference in the proportion of patients adequately blocked at 1 minute (12% for both groups), at 5 minutes (78% for ropivacaine, 70% for lignocaine/bupivacaine x 2 =0.83, P=0.36) or at 10 minutes (86% ropivacaine, 88% lignocaine/ bupivacaine x 2 =0.09, P=0.77).
On analysing the pain scores, there was also noted to be no significant difference in the median pain scores between the groups (both=0, Mann-Whitney U test, P=0.96).
Eyelid movement scores were not significantly different between the groups at 1, 5 or 10 minutes (Mann Whitney U tests, P=0.57, 0.24 and 0.83 respectively).
DISCUSSION
The sub-Tenon's block has a demonstrated high 
Number of patients with adequate blockade
patient acceptability rate of 98.8% 2 and is likely to increase in anaesthetic practice. The results of this study for both groups concur with the widespread findings on the effectiveness of the sub-Tenon's approach for cataract surgery.
While the technique has been gaining increasing acceptance, the choice of solution used has not been looked at as closely. In the prospective study by Guise 3 , their figures indicate a strong preference by anaesthetists for using the traditional lignocaine/ bupivacaine mixture (76.7%), compared to 1% ropivacaine (17.2%), with others using lignocaine alone (6%) and other unspecified solutions (generally omitting hyaluronidase).
A small study by Ripart and colleagues 10 trialed the use of mepivacaine which found a clinically minor difference in onset time, improved reliability of block and shorter duration of action when compared to the traditional lignocaine/bupivacaine mixture but this has yet to be validated with a wider study.
The lignocaine/bupivacaine mixture has been classically used with a good safety profile and minimal reported complications when used in a sub-Tenon's block. While there remains a theoretical cardiotoxicity with bupivacaine, no cases to date have been reported with the amounts used in a sub-Tenon's block. The main disadvantage of this mixture is the lack of a commercial pre-mix solution. This could translate into inherent problems with maintaining sterility and drug dosage errors.
Ropivacaine is a local anaesthetic that has been used in many clinical situations. It has an increasingly recognized safety profile even in situations of inadvertent administration of doses beyond recommended safety guidelines 5 . There is also the added convenience of using a single clinically appropriate solution. Its effectiveness and complication profile in the context of a sub-Tenon's block, to our knowledge, has not been verified although it has gained widespread acceptance and use for this technique.
This study indicates that ropivacaine appears to be a clinically appropriate solution. With respect to onset times and the adequate duration of anaesthesia and akinesia, as well as complication/side effect profiles, there is little or no clinical difference from the traditionally used lignocaine/bupivacaine mixture. As discussed, there are practical and some theoretical advantages in choosing ropivacaine, and this study validates the choice of this drug as an appropriate alternative to the traditional solutions used.
